Tag: liver disease diagnostics market outlook

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Liver Disease Diagnostics Market Size, Value And Growth Trends Through 2030

The market for liver disease diagnostics has experienced robust expansion recently, projecting a rise from $38.95 billion in 2025 to $41.84 billion in 2026, reflecting a compound annual growth rate of 7.4%. This historical growth trajectory is largely fueled by a greater incidence of hepatitis infections, escalating alcohol consumption, the early adoption of blood-based liver assessments, a growing number of liver cirrhosis cases, and the enhancement of diagnostic facilities within hospitals.

The market for diagnosing liver ailments is projected for substantial expansion in the ensuing years, anticipating a reach of $55.17 billion by 2030, propelled by a compound annual growth rate (CAGR) of 7.2%. This anticipated upswing is largely fueled by an increasing prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), heightened consciousness surrounding proactive liver health management, greater incorporation of sophisticated imaging modalities, the broadening scope of public health assessment initiatives, and amplified healthcare expenditures dedicated to diagnostic procedures. Key developments shaping this period include a burgeoning need for detecting liver conditions at their nascent stages, a surge in the utilization of non-invasive diagnostic methods, intensified screening efforts for fatty liver and fibrotic changes, a broader implementation of regular liver function assessments, and an elevated clinical emphasis on tracking disease advancement.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Liver Disease Diagnostics Market Opportunity Drivers: What Is Creating New Revenue Potential?

The escalating patterns of alcohol consumption are poised to be a significant catalyst for the expansion of the liver disease diagnostics sector in the foreseeable future, influenced by evolving societal attitudes, enhanced accessibility, broader availability, and escalating stress levels or mental health concerns. These diagnostic tools play a vital role in assessing how alcohol intake affects liver well-being, enabling the identification of nascent indicators of hepatic injury, including conditions like fatty liver, hepatitis, or cirrhosis. Illustrating this trend, data from December 2024, courtesy of the Bureau of Labor Statistics, reveals that in 2023, average household expenditures in the U.S. reached $294 for in-home alcohol purchases and $343 for alcohol consumed away from home, underscoring the heightened consumption that, in turn, fuels the market for liver disease diagnostic solutions.

Liver Disease Diagnostics Market Segment Landscape: Which Areas Lead Market Development?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

Liver Disease Diagnostics Market Innovation Trends Driving Future Development

Leading corporations within the liver disease diagnostics sector are prioritizing the creation of novel approaches, encompassing non-surgical instruments for liver evaluation, to advance diagnostic precision and effectiveness. A non-invasive liver assessment tool signifies diagnostic techniques that gauge liver health through methods such as elastography or analyses of blood samples, thereby circumventing the necessity for intrusive interventions like biopsies. As an illustration, in September 2024, City Imaging & Clinical, a diagnostic facility situated in India, introduced FibroScan, a non-surgical diagnostic instrument designed for liver assessment, with the objective of facilitating the early identification of hepatic conditions including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This sophisticated technology enables swift and precise quantification of liver tissue elasticity and fat accumulation without resorting to invasive procedures akin to biopsies. The examination itself is brief, generally spanning between five and fifteen minutes, and involves positioning a transducer against the skin overlying the liver. This transducer generates sound waves that are utilized to ascertain the rigidity of the liver tissue, aiding in the evaluation of fibrosis or the presence of scar tissue.

Liver Disease Diagnostics Market Industry Leaders And Market Competition

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Liver Disease Diagnostics Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the liver disease diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Liver Disease Diagnostics Market Size, Value And Growth Trends Through 2030

The market for liver disease diagnostics has experienced robust expansion recently, projecting a rise from $38.95 billion in 2025 to $41.84 billion in 2026, reflecting a compound annual growth rate of 7.4%. This historical growth trajectory is largely fueled by a greater incidence of hepatitis infections, escalating alcohol consumption, the early adoption of blood-based liver assessments, a growing number of liver cirrhosis cases, and the enhancement of diagnostic facilities within hospitals.

The market for diagnosing liver ailments is projected for substantial expansion in the ensuing years, anticipating a reach of $55.17 billion by 2030, propelled by a compound annual growth rate (CAGR) of 7.2%. This anticipated upswing is largely fueled by an increasing prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), heightened consciousness surrounding proactive liver health management, greater incorporation of sophisticated imaging modalities, the broadening scope of public health assessment initiatives, and amplified healthcare expenditures dedicated to diagnostic procedures. Key developments shaping this period include a burgeoning need for detecting liver conditions at their nascent stages, a surge in the utilization of non-invasive diagnostic methods, intensified screening efforts for fatty liver and fibrotic changes, a broader implementation of regular liver function assessments, and an elevated clinical emphasis on tracking disease advancement.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Liver Disease Diagnostics Market Opportunity Drivers: What Is Creating New Revenue Potential?

The escalating patterns of alcohol consumption are poised to be a significant catalyst for the expansion of the liver disease diagnostics sector in the foreseeable future, influenced by evolving societal attitudes, enhanced accessibility, broader availability, and escalating stress levels or mental health concerns. These diagnostic tools play a vital role in assessing how alcohol intake affects liver well-being, enabling the identification of nascent indicators of hepatic injury, including conditions like fatty liver, hepatitis, or cirrhosis. Illustrating this trend, data from December 2024, courtesy of the Bureau of Labor Statistics, reveals that in 2023, average household expenditures in the U.S. reached $294 for in-home alcohol purchases and $343 for alcohol consumed away from home, underscoring the heightened consumption that, in turn, fuels the market for liver disease diagnostic solutions.

Liver Disease Diagnostics Market Segment Landscape: Which Areas Lead Market Development?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

Liver Disease Diagnostics Market Innovation Trends Driving Future Development

Leading corporations within the liver disease diagnostics sector are prioritizing the creation of novel approaches, encompassing non-surgical instruments for liver evaluation, to advance diagnostic precision and effectiveness. A non-invasive liver assessment tool signifies diagnostic techniques that gauge liver health through methods such as elastography or analyses of blood samples, thereby circumventing the necessity for intrusive interventions like biopsies. As an illustration, in September 2024, City Imaging & Clinical, a diagnostic facility situated in India, introduced FibroScan, a non-surgical diagnostic instrument designed for liver assessment, with the objective of facilitating the early identification of hepatic conditions including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This sophisticated technology enables swift and precise quantification of liver tissue elasticity and fat accumulation without resorting to invasive procedures akin to biopsies. The examination itself is brief, generally spanning between five and fifteen minutes, and involves positioning a transducer against the skin overlying the liver. This transducer generates sound waves that are utilized to ascertain the rigidity of the liver tissue, aiding in the evaluation of fibrosis or the presence of scar tissue.

Liver Disease Diagnostics Market Industry Leaders And Market Competition

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Liver Disease Diagnostics Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the liver disease diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Liver Disease Diagnostics Market Size, Value And Growth Trends Through 2030

The market for liver disease diagnostics has experienced robust expansion recently, projecting a rise from $38.95 billion in 2025 to $41.84 billion in 2026, reflecting a compound annual growth rate of 7.4%. This historical growth trajectory is largely fueled by a greater incidence of hepatitis infections, escalating alcohol consumption, the early adoption of blood-based liver assessments, a growing number of liver cirrhosis cases, and the enhancement of diagnostic facilities within hospitals.

The market for diagnosing liver ailments is projected for substantial expansion in the ensuing years, anticipating a reach of $55.17 billion by 2030, propelled by a compound annual growth rate (CAGR) of 7.2%. This anticipated upswing is largely fueled by an increasing prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), heightened consciousness surrounding proactive liver health management, greater incorporation of sophisticated imaging modalities, the broadening scope of public health assessment initiatives, and amplified healthcare expenditures dedicated to diagnostic procedures. Key developments shaping this period include a burgeoning need for detecting liver conditions at their nascent stages, a surge in the utilization of non-invasive diagnostic methods, intensified screening efforts for fatty liver and fibrotic changes, a broader implementation of regular liver function assessments, and an elevated clinical emphasis on tracking disease advancement.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Liver Disease Diagnostics Market Opportunity Drivers: What Is Creating New Revenue Potential?

The escalating patterns of alcohol consumption are poised to be a significant catalyst for the expansion of the liver disease diagnostics sector in the foreseeable future, influenced by evolving societal attitudes, enhanced accessibility, broader availability, and escalating stress levels or mental health concerns. These diagnostic tools play a vital role in assessing how alcohol intake affects liver well-being, enabling the identification of nascent indicators of hepatic injury, including conditions like fatty liver, hepatitis, or cirrhosis. Illustrating this trend, data from December 2024, courtesy of the Bureau of Labor Statistics, reveals that in 2023, average household expenditures in the U.S. reached $294 for in-home alcohol purchases and $343 for alcohol consumed away from home, underscoring the heightened consumption that, in turn, fuels the market for liver disease diagnostic solutions.

Liver Disease Diagnostics Market Segment Landscape: Which Areas Lead Market Development?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

Liver Disease Diagnostics Market Innovation Trends Driving Future Development

Leading corporations within the liver disease diagnostics sector are prioritizing the creation of novel approaches, encompassing non-surgical instruments for liver evaluation, to advance diagnostic precision and effectiveness. A non-invasive liver assessment tool signifies diagnostic techniques that gauge liver health through methods such as elastography or analyses of blood samples, thereby circumventing the necessity for intrusive interventions like biopsies. As an illustration, in September 2024, City Imaging & Clinical, a diagnostic facility situated in India, introduced FibroScan, a non-surgical diagnostic instrument designed for liver assessment, with the objective of facilitating the early identification of hepatic conditions including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This sophisticated technology enables swift and precise quantification of liver tissue elasticity and fat accumulation without resorting to invasive procedures akin to biopsies. The examination itself is brief, generally spanning between five and fifteen minutes, and involves positioning a transducer against the skin overlying the liver. This transducer generates sound waves that are utilized to ascertain the rigidity of the liver tissue, aiding in the evaluation of fibrosis or the presence of scar tissue.

Liver Disease Diagnostics Market Industry Leaders And Market Competition

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Liver Disease Diagnostics Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the liver disease diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Liver Disease Diagnostics Market Progress Through 2030?

The liver disease diagnostics market has experienced robust growth in recent years. It is projected to expand from $38.95 billion in 2025 to $41.84 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historic growth is largely attributable to factors such as the increasing prevalence of hepatitis infections, rising alcohol consumption patterns, early reliance on blood-based liver tests, a growing incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market is projected to achieve significant expansion over the next few years, with its valuation expected to climb to $55.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth is driven by several factors, including the increasing incidence of NAFLD and NASH, a heightened awareness regarding preventive liver care, the growing adoption of advanced imaging techniques, the proliferation of population health screening programs, and greater healthcare spending on diagnostics. Prominent trends throughout this period include an escalating demand for early detection of liver diseases, a rise in the application of non-invasive diagnostic methods, more extensive screening for fatty liver and fibrosis, an expansion of routine liver function testing, and an increased clinical emphasis on monitoring disease progression.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Growth Drivers Are Expected To Support The Liver Disease Diagnostics Market Forward?

The growing intake of alcohol is projected to fuel the expansion of the liver disease diagnostics market moving forward. This rise in alcohol consumption is attributed to factors such as evolving social norms, greater economic accessibility, widespread availability, and increasing stress or mental health challenges. Liver disease diagnostics are essential for monitoring the effects of alcohol intake on liver health, assisting in the early detection of liver damage signs like fatty liver, hepatitis, or cirrhosis. For instance, in December 2024, the Bureau of Labor Statistics, a US-based government agency, indicated that in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Therefore, the increase in alcohol consumption is a primary driver for the growth of the liver disease diagnostics market.

What Are The Major Segment Categories Within The Liver Disease Diagnostics Market?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

What Trends Are Influencing The Future Of The Liver Disease Diagnostics Market?

Leading companies in the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive methods for liver assessment, to create more precise and effective diagnostic approaches. A non-invasive tool for liver assessment refers to diagnostic techniques that evaluate liver conditions using methods like elastography or blood tests, thereby eliminating the need for invasive procedures such as biopsies. For example, in September 2024, City Imaging & Clinical, an India-based diagnostic center, introduced FibroScan, a non-invasive diagnostic tool for liver assessment, intended for the early detection of liver ailments including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology enables rapid and accurate measurements of liver stiffness and fat content without requiring invasive interventions like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, and involves placing a probe on the skin over the liver. The probe then emits sound waves, which measure liver tissue stiffness, aiding in the assessment of fibrosis or scarring.

Which Organizations Are Involved In The Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Commands The Largest Share Of The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Liver Disease Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company

Hepatitis Diagnostic Tests Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Liver Diseases Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Clinical Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Liver Disease Diagnostics Market Compare Between 2026 And 2030?

The liver disease diagnostics market has demonstrated robust growth in recent years. It is projected to increase from $38.95 billion in 2025 to $41.84 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to factors such as the increasing prevalence of hepatitis infections, evolving alcohol consumption patterns, the early adoption of blood-based liver tests, a rising incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market is projected for significant expansion over the coming years. Its value is set to reach $55.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from factors such as the increasing prevalence of NAFLD and NASH, heightened understanding of preventive liver care, wider implementation of advanced imaging methods, the broadening of population health screening initiatives, and elevated healthcare expenditure on diagnostic services. Key developments expected during this period involve a heightened need for detecting liver disease early, increased reliance on non-invasive diagnostic approaches, more extensive screening for fatty liver and fibrosis, a wider scope for routine liver function tests, and an intensifying clinical focus on monitoring disease progression.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Important Drivers Are Guiding The Liver Disease Diagnostics Market Growth?

The projected rise in alcohol intake is set to fuel the growth of the liver disease diagnostics market moving forward. This increase in alcohol consumption is attributed to factors like evolving social norms, enhanced affordability, broad availability, and escalating stress or mental health issues. Liver disease diagnostics are essential for monitoring the impact of alcohol consumption on liver health, assisting in the early detection of liver damage signs such as fatty liver, hepatitis, or cirrhosis. For instance, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Therefore, the upward trend in alcohol consumption is driving the expansion of the liver disease diagnostics market.

How Is The Liver Disease Diagnostics Market Segmented Across Different Segment Categories?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

What Trends Are Influencing The Evolution Of The Liver Disease Diagnostics Market?

Companies at the forefront of the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive methods for liver assessment, to create more accurate and efficient diagnostic techniques. A non-invasive tool for liver assessment refers to diagnostic approaches that evaluate liver conditions using methods like elastography or blood tests, thus avoiding the need for invasive procedures like biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment. Its aim is the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology enables rapid and precise measurements of liver stiffness and fat content without requiring invasive procedures like biopsies. The process is quick, typically lasting 5 to 15 minutes, and involves placing a probe on the skin above the liver. The probe then emits sound waves, which measure liver tissue stiffness, aiding in the assessment of fibrosis or scarring.

Which Organizations Play A Role In The Liver Disease Diagnostics Market Landscape?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Get The Full Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Holds The Highest Market Share In The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Liver Disease Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company

Hepatitis Diagnostic Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Liver Diseases Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Clinical Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Liver Disease Diagnostics Market Expected To Change Between 2026 And 2030?

The liver disease diagnostics market size has demonstrated robust growth in recent years. It is anticipated to increase from $38.95 billion in 2025 to $41.84 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to the increasing prevalence of hepatitis infections, rising alcohol consumption patterns, an early reliance on blood-based liver tests, the growing incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $55.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth is driven by factors such as the increasing prevalence of NAFLD and NASH, heightened understanding of proactive liver care, wider implementation of sophisticated imaging methods, an increase in population health screening initiatives, and greater investment in diagnostic healthcare services. Key trends anticipated during this period encompass an escalating need for prompt liver disease identification, a surge in the application of non-invasive diagnostic approaches, more extensive screening for fatty liver and fibrosis, broadened routine liver function assessments, and an increased clinical emphasis on tracking disease progression.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Economic Or Industry Drivers Are Impacting The Liver Disease Diagnostics Market?

A rise in alcohol consumption is anticipated to stimulate the expansion of the liver disease diagnostics market moving forward. The intake of alcohol is growing, attributed to factors such as shifting social customs, greater affordability, widespread accessibility, and an increase in stress or mental health issues. Liver disease diagnostics are essential for observing the impact of alcohol consumption on liver well-being, aiding in the detection of initial indicators of liver damage like fatty liver, hepatitis, or cirrhosis. As an illustration, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Consequently, the increasing alcohol consumption is fueling the growth of the liver disease diagnostics market.

How Is The Liver Disease Diagnostics Market Structured Across Different Segments?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

Which Trends Are Impacting The Growth Of The Liver Disease Diagnostics Market?

Leading companies operating in the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive tools for liver assessment, to establish more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic methods that evaluate liver conditions using techniques like elastography or blood tests, thereby avoiding the necessity for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, introduced FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at the early detection of liver diseases including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology enables rapid and accurate measurements of liver stiffness and fat content without requiring invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, and involves positioning a probe on the skin over the liver. The probe emits sound waves, which gauge liver tissue stiffness, assisting in the assessment of fibrosis or scarring.

Which Major Players Dominate The Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Read the full liver disease diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Are The Top-Performing Regions Within The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Liver Disease Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company

Hepatitis Diagnostic Tests Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Liver Diseases Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Clinical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model